Martin Shkreli must forfeit $7.36 million, turn over stake in ultra-rare Wu-Tang Clan album: Judge
Convicted fraudster Martin Shkreli was ordered to forfeit $7.36 million as part of his criminal sentence on Monday.
Shkreli must forfeit his stake in the Wu-Tang Clan album "Once Upon a Time in Shaolin" to help satisfy that order.
Shkreli gained infamy as the "pharma bro" after raising the price of the **** Daraprim by more than 5,000 percent, but was convicted of securities fraud charges unrelated to that ****.
Convicted fraudster Martin Shkreli will have to forfeit $7.36 million to the federal government as part of his upcoming criminal sentence, a judge ruled Monday.
Judge Kiyo Matsumoto said that in order to satisfy that award amount Shkreli — who was said to be completely cash-broke last year by his lawyer — must forfeit his interest in a set of "substitute" assets.
Those assets are: $5 million in cash in an E-Trade brokerage account that previously had secured his release bond; Shkreli's stake in the **** company Vyera Pharmaceuticals; the one-of-a-kind Wu-Tang Clan album "Once Upon a Time in Shaolin"; the Lil' Wayne album "The Carter V"; and a painting by Pablo Picasso.
Privately held Vyera was originally known as Turing Pharmaceuticals, which Shkreli founded in 2015. His lawyer Benjamin Brafman last June said Shkreli's share of Vyera was worth between $30 million and $50 million.
Later in 2015 Shkreli gained widespread public notoriety after Turing purchased the anti-parasite **** Daraprim — which is used to treat a parasitic condition found in some pregnant women, babies and people with HIV — and raised the price by more than 5,000 percent, from $13.50 per pill to $750 per pill.
...